Aspen Pharmacare Holdings Limited

Johannesburg Stock Exchange:APN.JO

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🛍 Specialty Retail

Location

South Africa

Market Cap

USD 2.99 B

Share Price

USD 6.77

Avg Daily Volume

2,211,997

Change (1 day)

1.95%

Change (1 year)

-50.69%

Change (YTD)

-22.49%

Aspen Pharmacare Holdings Limited Depreciation And Amortization for the year ending June 30, 2024: USD 108.54 M

Aspen Pharmacare Holdings Limited Depreciation And Amortization is USD 108.54 M for the year ending June 30, 2024, a 14.75% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Aspen Pharmacare Holdings Limited Depreciation And Amortization for the year ending June 30, 2023 was USD 94.59 M, a -9.48% change year over year.
Aspen Pharmacare Holdings Limited Depreciation And Amortization for the year ending June 30, 2022 was USD 104.49 M, a -9.18% change year over year.
Aspen Pharmacare Holdings Limited Depreciation And Amortization for the year ending June 30, 2021 was USD 115.05 M, a 25.47% change year over year.
Aspen Pharmacare Holdings Limited Depreciation And Amortization for the year ending June 30, 2020 was USD 91.69 M, a 1.94% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Depreciation And Amortization	Dividends Paid	Common Stock Issued	Common Stock Repurchased

Johannesburg Stock Exchange: APN.JO

Aspen Pharmacare Holdings Limited

CEO	Mr. Stephen Bradley Saad BCom, CA(SA)
IPO Date	Jan. 4, 2000
Location	South Africa
Headquarters	Aspen Place
Employees	8,867
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🛍 Specialty Retail

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. The company was founded in 1850 and is headquartered in Durban, South Africa.